Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• HIV 100%
• Small Cell Lung Cancer 100%
• Neoplasm 50%
• Small Interfering RNA 50%
• Lentivirus Vector 50%
• Lentivirus 50%
• Adenovirus Vector 50%
• NOD SCID Mouse 50%
• Adenoviridae 50%

Keyphrases

• RNA Interference 100%
• Small Cell Lung Carcinoma 100%
• Gene Therapy 100%
• S-phase Kinase-associated Protein 2 (Skp2) 100%
• Cell Growth 20%
• P27Kip1 20%
• Cancer Cells 10%
• Subcutaneous Tumor 10%
• SCID Mice 10%
• Cancer Gene Therapy 10%
• Small Interfering RNA (siRNA) 10%
• C-Myc 10%
• Dysregulation 10%
• Adenovirus 10%
• In Vitro Cells 10%
• Adenoviral Vector 10%
• Intratumoral Administration 10%
• Lentiviral Vector 10%
• Lung Carcinoma Cells 10%
• Cell Cycle Regulators 10%
• Lentivirus 10%
• Carcinoma Cell Line 10%

Immunology and Microbiology

• Lung 100%
• RNAI 100%
• Human Immunodeficiency Virus 40%
• Cell Cycle 40%
• Cancer Cell 20%
• Cell Growth 20%
• Oncogene C Myc 20%
• NOD SCID Mouse 20%
• Lentivirus 20%
• Adenoviridae 20%
• Lentivirus Vector 20%
• Adenovirus Vector 20%
• Lung Small Cell Carcinoma Cell Line 20%
• Tumor Gene 20%
• In Vitro 20%